GISV - Investview Profile, Share Price, Market Analysis, Charts, Fundamentals - CSIMarket

Company Name, Ticker, Customers, else..

Investview Inc. (GISV)

Other Ticker:

Sector • Services Industry • Professional Services

Industry • Professional Services

Sector • Services

Price: $0.0000 $0.00

%

Day's High:	0.00	Week Perf:
Day's Low:	$ 0.00	30 Day Perf:
Volume (M):	0	52 Wk High:	$ 0.00
Volume (M$):	$ 0	52 Wk Avg:	$0.00
Open:	$0.00	52 Wk Low:	$0.00

GISV Charts & Quotes

GISV Charts & Quotes

Company's Segments

Market Capitalization (Millions $)	-
Shares Outstanding (Millions)	3,760
Employees	-
Revenues (TTM) (Millions $)	84
Net Income (TTM) (Millions $)	-27
Cash Flow (TTM) (Millions $)	15
Capital Exp. (TTM) (Millions $)	7

Investview Inc.

Company Address: 234 Industrial Way West Eatontown 7724 NJ
Company Phone Number: 889-4300 Stock Exchange / Ticker: GISV

GISV is expected to report next financial results on November 21, 2022.

Reports on Competition

List of Competitors

Competitors by Segment

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Stock Performances by Major Competitors

Year to Date	Decrease / Increase

• View Complete Report

News

Clene Inc.

Clene Inc reported most recent fiscal period operating deficit of $-13.595 millions

Clene Inc reported disastrous most recent fiscal period, where Sales faded by -82.59% to $0.04 millions and loss per share has widen to $-0.07, from the same quarter a year ago.

Pyxis Oncology Inc.

Redemption of Losses but Revenues Unchanged at Pyxis Oncology Inc in the second quarter of 2022

In the second quarter of 2022 Pyxis Oncology Inc decreased loss of $-0.79 per share compared to $-8.95 a year ago and improved from $-0.97 per share from the previous quarter.

Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc disclosed a similar performance like a year before in the financial interval ending Jun 30 2022

In the financial interval ending Jun 30 2022 Alaunos Therapeutics Inc lost money of $-0.05 per share compared to $-0.11 a year ago and from $-0.05 per share from the previous quarter.

Inozyme Pharma Inc.

Inozyme Pharma Inc announced top-line remained unaltered in the second quarter of 2022

In the second quarter of 2022 Inozyme Pharma Inc decreased loss of $-0.38 per share compared to $-0.53 a year ago and improved from $-0.71 per share from the previous quarter.

Greenlight Biosciences Holdings Pbc

Greenlight Biosciences Holdings Pbc declared in the financial second quarter of 2022

For the financial second quarter of 2022 Greenlight Biosciences Holdings Pbc increased losses at $-0.42 per share, compared to results of $0.00 per share a year ago quarter, In the previous quarter company realized $-0.34 per share.

GISV's Valuation	Current
Price to Earnings PE Ratio (TTM)	-
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	-
Price to Sales (Expected)	-
Price to Book	-
PEG (TTM)	-

GISV's Financial Strength	Current
Quick Ratio	2
Working Capital Ratio	2.41
Leverage Ratio (MRQ)	0.7
Total Debt to Equity	0.36
Interest Coverage (TTM)	-
Debt Coverage (TTM)	-

Per Share	Current
Earnings (TTM)	-0.01 $
Revenues (TTM)	0.02 $
Cash Flow (TTM)	0 $
Cash	0.01 $
Book Value	0.01 $
Dividend (TTM)	0 $

GISV's Efficiency	Current
Revenue per Employee (TTM)	-
Net Income per Employee (TTM)	-
Receivable Turnover Ratio (TTM)	36.35
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	2.24

GISV's Profitability Ratio	Current
Gross Margin (MRQ)	-
Operating Margin (MRQ)	24.14 %
Net Margin (MRQ)	13.4 %
Net Cash Flow Margin (MRQ)	-35.69 %
Effective Tax Rate (TTM)	-

Management Effectiveness	Current
Return On Assets (TTM)	-
Return On Investment (TTM)	-
Return On Equity (TTM)	-
Dividend Yield	-
Pay out Ratio (TTM)	-

GISV's Valuation
Price to Earnings PE Ratio (TTM)	-
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	-
Price to Sales (Expected)	-
Price to Book	-
PEG (TTM)	-

Per Share
Earnings (TTM)	-0.01 $
Revenues (TTM)	0.02 $
Cash Flow (TTM)	0 $
Cash	0.01 $
Book Value	0.01 $
Dividend (TTM)	0 $

GISV's Financial Strength
Quick Ratio	2
Working Capital Ratio	2.41
Leverage Ratio (MRQ)	0.7
Total Debt to Equity	0.36
Interest Coverage (TTM)	-
Debt Coverage (TTM)	-

• View Valuation Comparisons

• View Growth Rates Comparisons

GISV's Efficiency
Revenue per Employee (TTM)	-
Net Income per Employee (TTM)	-
Receivable Turnover Ratio (TTM)	36.35
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	2.24

GISV's Profitability Ratio
Gross Margin (MRQ)	-
Operating Margin (MRQ)	24.14 %
Net Margin (MRQ)	13.4 %
Net Cash Flow Margin (MRQ)	-35.69 %
Effective Tax Rate (TTM)	-

Management Effectiveness
Return On Assets (TTM)	-72.74 %
Return On Investment (TTM)	-105.72 %
Return On Equity (TTM)	-184.38 %
Dividend Yield	-
Pay out Ratio (TTM)	-

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Investview's Segments

• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar HLGN's Profile Stock Price HLGN's Financials Business Description Fundamentals Charts & Quotes HLGN's News Suppliers HLGN's Competitors Customers & Markets Economic Indicators HLGN's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Industries

At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets

At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071